GFP image analysis in the mouse orthotopic bladder cancer model

Oncology Reports

Volumn 20, Issue 3, 2008, Pages 543-547

  De Velasco, Marco A ^a   Tanaka, Motoyoshi ^a   Anai, Satoshi ^b   Tomioka, Atsushi ^b   Nishio, Kazuto ^a   Uemura, Hirotsugu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bladder cancer; Computer assisted image analysis; Green fluorescent proteins; Mouse

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; GREEN FLUORESCENT PROTEIN; ANTINEOPLASTIC ANTIBIOTIC; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER REGRESSION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; FEMALE; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; IMAGE ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; ANIMAL; BLADDER TUMOR; CELL CULTURE; DISEASE MODEL; DRUG SCREENING; HUMAN; INCIDENCE; INTRAVESICAL DRUG ADMINISTRATION; NUDE MOUSE;

ADMINISTRATION, INTRAVESICAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DISEASE MODELS, ANIMAL; DOXORUBICIN; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; INCIDENCE; MICE; MICE, NUDE; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 54549102240     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000040     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, et al: Cancer Statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Cancer Statistics in Japan 2005; Foundation for the Promotion of Cancer Research (http://www.fpcr.or.jp/publication/pdf/statistics2005.pdf).
3. Kakizoe T: Development and progression of urothelial carcinoma. Cancer Sci 97: 821-828, 2006.
4. Amling CL: Diagnosis and management of superficial bladder cancer. Curr Probl Cancer 25: 224-278, 2001.
5. Soloway MS, De Kernion JB, Rose D, et al: Effect of chemotherapeutic agents on bladder cancer: a new animal model. Surg Forum 24: 542-544, 1973.
6. Watanabe T, Shinohara N, Sazawa A, et al: An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Cancer Gene Ther 7: 1575-1580, 2000.
7. Zhou JH, Rosser CJ, Tanaka M, et al: Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression. Cancer Gene Ther 8: 681-686, 2002.
8. Tanaka M, Gee JR, De la Cerda J, et al: Noninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytology. J Urol 3: 975-978, 2003.
9. Caceres G, Zhu XY, Jiao JA, et al: Imaging of luciferase and GFP-transfected human tumours in nude mice. Luminescence 24: 218-223, 2003.
10. Nogawa M, Yuasa T, Kimura S, et al: Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest 115: 978-985, 2005.
11. Brocks CP, Buttner H and Bohle A: Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer. J Urol 174: 1115-1118, 2005.
12. Wu Q, Mahendran R and Esuvaranathan K: Nonviral cytokine gene therapy on an orthotopic bladder cancer model. Clin Cancer Res 9: 4522-4528, 2003.
13. Singh AV, Franke AA, Blackburn GL and Zhou JR: Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 66: 1851-1858, 2006.
14. Tazaki H and Tachibana M: Studies on KU-1 and KU-7 cells as an in vitro model of human transitional cell carcinoma of urinary bladder. Hum Cell 1: 78-83, 1988.
15. Oliveira PA, Colaco A, De la Cruz, et al: Experimental bladder carcinogenesis-rodent models. Exp Oncol 28: 2-11, 2006.
16. Hegele A, Dalpke A, Heeg K, et al: Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model. Tumour Biol 26: 274-280, 2005.
17. Hoffman RM: Imaging tumor angiogenesis with fluorescent proteins. APMIS 112: 441-449, 2004.
18. Gunther JH, Frambach M, Deinert I, et al: Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49). J Urol 161: 1702-1706, 1999.
19. Wu Q, Esuvaranathan K and Mahendran R: Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter. Clin Cancer Res 10: 6977-6984, 2004.
20. Ponomarev V, Doubrovin M, Serganova I, et al: A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 31: 740-751, 2004.
21. Yanagihara K, Takigahira M, Takeshita F, et al: A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination. Cancer Res 66: 7532-7539, 2006.